Kakkalide ameliorates endothelial insulin resistance by suppressing reactive oxygen species-associated inflammation

Journal of Diabetes

Volumn 5, Issue 1, 2013, Pages 13-24

  Zhang, Dongyan ^a   Gao, Xuejiao ^a   Wang, Qi ^a   Qin, Minjian ^a   Liu, Kang ^a   Huang, Fang ^a   Liu, Baolin ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Endothelial dysfunction; Inflammation; Insulin resistance; Kakkalide; Reactive oxygen species

Indexed keywords

CARBONYL CYANIDE CHLOROPHENYLHYDRAZONE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; I KAPPA B KINASE; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; INTERLEUKIN 6; ISOFLAVONE; KAKKALIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; SERINE; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA; TYROSINE; UNCLASSIFIED DRUG;

AORTA; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME SYNTHESIS; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATION; INSULIN RESISTANCE; MEMBRANE DEPOLARIZATION; MITOCHONDRIAL MEMBRANE POTENTIAL; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UMBILICAL VEIN ENDOTHELIAL CELL; VASODILATATION;

BASE SEQUENCE; BLOTTING, WESTERN; CELLS, CULTURED; DNA PRIMERS; ENDOTHELIUM, VASCULAR; GLYCOSIDES; HUMANS; INSULIN; INSULIN RECEPTOR SUBSTRATE PROTEINS; INSULIN RESISTANCE; ISOFLAVONES; MEMBRANE POTENTIAL, MITOCHONDRIAL; NITRIC OXIDE; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; REACTIVE OXYGEN SPECIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; VASODILATION;

EID: 84873477572     PISSN: 17530393     EISSN: 17530407     Source Type: Journal    
DOI: 10.1111/1753-0407.12017     Document Type: Article

References (30)

1. Niiho Y, Yamazaki T, Nakajima Y et al. Pharmacological studies on Puerariae Flos I. The effects of puerariae flos on alcoholic metabolism and spontaneous movement in mice. Yakugaku Zasshi. 1989; 109: 424-31 (in Japanese with English abstract).
2. Song LR, Hong X, Ding XL, Zang ZY. A Modern Dictionary of Chinese Traditional Medicine. People's Health Press, China, 2001.
3. Yamazaki T, Nakajima Y, Niho Y et al. Pharmacological studies on Puerariae flos III: Protective effects of kakkalide on ethanol-induced lethality and acute hepatic injury in mice. J Pharm Pharmacol. 1997; 49: 831-3.
4. Han YO, Han MJ, Park SH, Kim DH. Protective effects of kakkalide from Flos Puerariae on ethanol-induced lethality and hepatic injury are dependent on its biotransformation by human intestinal microflora. J Pharmacol Sci. 2003; 93: 331-6.
5. Lee HU, Bae EA, Kim DH. Hepatoprotective effects of irisolidone on tert-butyl hyperoxide-induced liver injury. Biol Pharm Bull. 2005; 28: 531-3.
6. Min SW, Kim DH. Kakkalide and irisolidone: HMG-CoA reductase inhibitors isolated from the flower of Pueraria thunbergiana. Biol Pharm Bull. 2007; 30: 1965-8.
7. Shin JE, Bae EA, Lee YC, Ma JY, Kim DH. Estrogenic effect of main components kakkalide and tectoridin of Puerariae Flos and their metabolites. Biol Pharm Bull. 2006; 29: 1202-6.
8. Park JS, Woo MS, Kim DH et al. Anti-inflammatory mechanisms of isoflavone metabolites in lipopolysaccharide-stimulated microglial cells. J Pharmacol Exp Ther. 2007; 320: 1237-45.
9. Kang KA, Zhang R, Piao MJ et al. Protective effect of irisolidone, a metabolite of kakkalide, against hydrogen peroxide induced cell damage via antioxidant effect. Bioorg Med Chem. 2008; 16: 1133-41.
10. Yip J, Facchini FS, Reaven GM. Resistance to insulin-mediated glucose disposal as a predictor of cardiovascular disease. J Clin Endocrinol Metab. 1998; 83: 2273-6.
11. Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circ Res. 2010; 107: 1058-70.
12. Shinozaki K, Kashiwagi A, Masada M, Okamura TJ. Stress and vascular responses: Oxidative stress and endothelial dysfunction in the insulin-resistant state. Pharmacol Sci. 2003; 91: 187-91.
13. De Vriese AS, Verbeuren TJ, Van de Voorde J, Lameire NH, Vanhoutte PM. Endothelial dysfunction in diabetes. Br J Pharmacol. 2000; 130: 963-74.
14. Nishikawa T, Kukidome D, Sonoda K et al. Impact of mitochondrial ROS production on diabetic vascular complications. Diabetes Res Clin Pract. 2007; 77 (Suppl. 1): S41-5.
15. Cersosimo E, DeFronzo RA. Insulin resistance and endothelial dysfunction: The road map to cardiovascular diseases. Diabetes Metab Res Rev. 2006; 22: 423-36.
16. Steinberg HO, Tarshoby M, Monestel R et al. Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation. J Clin Invest. 1997; 100: 1230-9.
17. Steinberg HO, Paradisi G, Hook G, Crowder K, Cronin J, Baron AD. Free fatty acid elevation impairs insulin-mediated vasodilation and nitric oxide production. Diabetes. 2000; 49: 1231-8.
18. Carlsson M, Wessman Y, Almgren P, Groop L. High levels of nonesterified fatty acids are associated with increased familial risk of cardiovascular disease. Arterioscler Thromb Vasc Biol. 2000; 20: 1588-94.
19. Lambertucci RH, Hirabara SM, Silveira Ldos R, Levada-Pires AC, Curi R, Pithon-Curi TC. Palmitate increases superoxide production through mitochondrial electron transport chain and NADPH oxidase activity in skeletal muscle cells. J Cell Physiol. 2008; 216: 796-804.
20. Zamzami N, Marchetti P, Castedo M et al. Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo. J Exp Med. 1995; 181: 1661-72.
21. Carmody RJ, Cotter TG. Oxidative stress induces caspase-independent retinal apoptosis in vitro. Cell Death Differ. 2000; 7: 282-91.
22. Alberici LC, Vercesi AE, Oliveira HC. Mitochondrial energy metabolism and redox responses to hypertriglyceridemia. Bioenerg Biomembr. 2011; 43: 19-23.
23. Goldin A, Beckman JA, Schmidt AM, Creager MA. Advanced glycation end products: Sparking the development of diabetic vascular injury. Circulation. 2006; 114: 597-605.
24. Yamagishi S, Fujimori H, Yonekura H, Yamamoto Y, Yamamoto H. Advanced glycation endproducts inhibit prostacyclin production and induce plasminogen activator inhibitor-1 in human microvascular endothelial cells. Diabetologia. 1998; 41: 1435-41.
25. Kaneto H, Xu G, Fujii N, Kim S, Bonner-Weir S, Weir GC. Involvement of c-Jun N-terminal kinase in oxidative stress-mediated suppression of insulin gene expression. Biol Chem. 2002; 277: 30010-18.
26. Houstis N, Rosen ED, Lander ES. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature. 2006; 440: 944-8.
27. Kaneto H, Nakatani Y, Miyatsuka T et al. Possible novel therapy for diabetes with cell-permeable JNK inhibitory peptide. Nat Med. 2004; 10: 1128-32.
28. Min SW, Park YJ, Kim DH. Kakkalide and its metabolite irisolidone ameliorate carrageenan-induced inflammation in mice by inhibiting NF-κB pathway. Inflammation. 2011; 34: 344-51.
29. Gual P, Le Marchand-Brustel Y, Tanti JF. Positive and negative regulation of insulin signaling through IRS-1 phosphorylation. Biochimie. 2005; 87: 99-109.
30. Hirosumi J, Tuncman G, Chang L et al. A central role for JNK in obesity and insulin resistance. Nature. 2002; 420: 333-6.